With over 32 years of leadership experience across the global healthcare and pharmaceutical sectors, Mr. Sharma’s career is a masterclass in vision, resilience, and transformation. He has held senior leadership roles including President at Synokem Pharmaceuticals Ltd, Cadila Pharmaceuticals Ltd, and head representative positions in Ipca Laboratories Ltd (Russia and CIS countries) and J.B. Chemicals & Pharmaceuticals Ltd (Ukraine).
Mr. Sharma has a proven track record in building both international exports and domestic pharmaceutical businesses into remarkable success stories. At the recently held Economic Times Healthcare Conclave 2025, he was awarded for Excellence in Outstanding Contribution to the Pharmaceuticals & Healthcare Sector.
Recognized among India’s Top 10 Most Influential Healthcare Leaders 2025 by TradeFlock, his journey reflects a unique blend of science, strategy, and purpose:
-
Learning Russian to successfully launch molecules in Siberia and the Far East
-
Building extensive sales networks in India and globally
-
Pioneering therapies across cardiology, neurology, rheumatology, psychiatry, dermatology, and women’s health
-
Introducing Sartans, Statins, and SSRIs in India for the first time and expanding these therapies internationally
With his visionary leadership, scientific expertise, and unwavering focus on patient safety and outcomes, we look forward to steering Biodeal Pharmaceuticals into a future of innovation, growth, and global excellence.
Also read: Viksit Workforce for a Viksit Bharat
Do Follow: The Mainstream formerly known as CIO News LinkedIn Account | The Mainstream formerly known as CIO News Facebook | The Mainstream formerly known as CIO News Youtube | The Mainstream formerly known as CIO News Twitter |The Mainstream formerly known as CIO News Whatsapp Channel | The Mainstream formerly known as CIO News Instagram
About us:
The Mainstream formerly known as CIO News is a premier platform dedicated to delivering latest news, updates, and insights from the tech industry. With its strong foundation of intellectual property and thought leadership, the platform is well-positioned to stay ahead of the curve and lead conversations about how technology shapes our world. From its early days as CIO News to its rebranding as The Mainstream on November 28, 2024, it has been expanding its global reach, targeting key markets in the Middle East & Africa, ASEAN, the USA, and the UK. The Mainstream is a vision to put technology at the center of every conversation, inspiring professionals and organizations to embrace the future of tech.
